Gene Therapy Tools

Creative Biolabs is a supplier of products designed for use in neuroscience research. We offer a variety of neuroscience research tools and services, covering areas such as basic research, neurological diseases, neural cell culture, and neural model construction. After extensive product development, we are pleased to announce the launch of several new tools for gene silencing and expression. Our products will assist you in achieving your research objectives, whether you are looking to knock out, knock in, knock down, or overexpress your target.

We are always expanding the product list. Please contact us and tell us your requirements and we'll customize the products according to your needs.

Product Overview

Advances in genome engineering, from the study of disease mechanisms to drug development, are enabling researchers to make unprecedented breakthroughs in neurological disorders. Our selection comprises, but is not restricted to:

• RNAi Substrates: We provide three types of small RNAs for RNAi: short hairpin RNA (shRNA), small interfering RNA (siRNA), and microRNA (miRNA). Creative Biolabs offers an extensive selection of products for many popular targets in neurological disorders, such as APOE, Tau, SOD1, CTNNB1, Huntingtin and others. We can also tailor RNAi solutions to match your specific requirements.
• Gene Expression Vectors: With our ready-to-use expression vectors, you can skip the time-consuming cloning, validation, and sequence analysis steps. We provide an array of expression systems, promoter clones, fusion tags and screening markers, and you can customize or purchase pre-made, ready-to-use expression vectors.
• Antisense Oligonucleotides (ASOs): We now have a list of ready-to-use ASO products for research into a number of neurological disorders. If you have identified a prospective RNA target and are looking for the best ASO, we can provide a customized solution.
• Viral Tracers: Viral products play a pivotal role in gene therapy, particularly as gene delivery vectors. By engineering viruses to remove their pathogenicity while preserving their delivery capabilities, viral vectors have become a cornerstone of gene therapy.

Advantages

• Strict quality control and cost-effective.
• Available on request for flexible synthesis sizes and bulk orders.
• Cover several kinds of targets for neurological disorders.

Trending Products

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Huntington's Disease

Loading...

NoGeneST™ Dystrophin, exon 45-ASO, Antisense Oligonucleotide [CAT#: NRYF-0625-XY28]

Applications:

Our Dystrophin, exon 45-ASO targets a specific exon of the Dystrophin gene, important for studying Duchenne Muscular Dystrophy. It enables investigation of how exon 45 - related Dystrophin abnormalities affect neural - muscle communication, nerve - mediated muscle function, and the underlying neurological aspects of the disease.

Compare Inquiry

Datasheet MSDS

NoGeneST™ Dystrophin, exon 53-ASO, Antisense Oligonucleotide [CAT#: NRYF-0625-XY23]

Applications:

Our Dystrophin, exon 53-ASO targets a specific exon of the Dystrophin gene, crucial for understanding Duchenne Muscular Dystrophy. It allows for the study of how exon 53 - related Dystrophin abnormalities affect neural - muscle interactions, nerve - mediated muscle control, and the underlying neurological mechanisms of the disease.

Compare Inquiry

Datasheet MSDS

NoGeneST™ Dystrophin, exon 51-ASO, Antisense Oligonucleotide [CAT#: NRYF-0625-XY20]

Applications:

Designed to target exon 51 of the Dystrophin gene, our ASO is valuable for studying Duchenne Muscular Dystrophy. Beyond muscle effects, it aids in exploring how Dystrophin exon 51 dysregulation impacts neuromuscular junction signaling and nervous system development, contributing to a more comprehensive understanding of the disease and potential therapeutic strategies.

Compare Inquiry

Datasheet MSDS

NoGeneST™ DMD-ASO, Antisense Oligonucleotide [CAT#: NRYF-0625-XY12]

Applications:

Our DMD-ASO is designed to target the Duchenne Muscular Dystrophy (DMD) gene. While primarily associated with muscle pathology, it also aids in exploring the impact of DMD gene dysregulation on neuromuscular junction function and potential secondary effects on the nervous system, providing insights into the broader disease mechanisms and possible neurological interventions.

Compare Inquiry

Datasheet MSDS